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Setting: Tuberculosis (TB) incidence is rising globally, with drug resistance becoming increas-
ingly problematic. Microbiological confirmation ensures correct anti-tuberculous chemo-
therapy.
Objective/design: We retrospectively analysed all TB cases diagnosed in Central Manchester in
2009 investigating how often we are not achieving microbiological diagnosis, factors influ-
encing this and whether opportunities to obtain microbiological samples are missed.
Results: 128/156 (82%) cases had samples sent for microbiology. Factors affecting this included
disease site, with ocular disease least likely to be sampled (p < 0.0001), and patient age (with
children less likely to be sampled pZ 0.002). Ethnicity did not affect sampling (n.s.). Overall,
92/156 (59%) cases were culture positive. Negative culture was related to specimen type
(p < 0.0001) and patient age (p Z 0.019), with children significantly less likely to have a pos-
itive culture. Ethnicity and disease site did not affect culture results. There was a trend to-
wards culture positivity being more common in pulmonary (75%) than non-pulmonary (46%)
disease (n.s.). In only 7 (4%), could samples have been sent where they were originally absent
(3) or further samples obtained where the cultures proved to be negative (4).
Conclusion: Despite an overall culture positive rate of 59%, opportunities to achieve microbi-
ological confirmation are seldom missed. In our centre, which is typical of UK practice, this61 276 4381; fax: þ44 161 276 4989.
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Diagnosis of TB by microbial culture 2023lack of capacity to increase microbiological confirmation, particularly in an era of increasing
importance of extra-pulmonary TB, is concerning. Improvements in sample acquisition and lab-
oratory methods are urgently required.
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Globally the impact of tuberculosis (TB) is vast; in 2011
there were 8.7 million new cases and 1.4 million deaths,
with only 66% diagnosed and notified to national pro-
grammes [1]. The World Health Organisation (WHO) rec-
ommends that guidelines for diagnosis and culture are
followed at a national level, according to national TB
incidence and prevalence of drug resistance. TB cases in
the UK rose from 6724 in 2000e8963 in 2011 [2]. There was
an overall culture positive rate of 59%, which was higher in
pulmonary (70%) versus non-pulmonary (48%) disease.
Currently the National Institute of Clinical Excellence
(NICE) guidance recommends that pulmonary disease is
diagnosed by the collection of multiple sputum samples
(spontaneous or induced) or broncho-alveolar lavage, with
treatment commenced soon after samples are taken [3].
NICE also recommend extra-pulmonary TB diagnosis, if
suspected, is achieved by sending samples for TB culture. In
the UK in 2011 52% of cases had pulmonary disease, a fall
from 59% in 2000e2003 [2]. The proportion of extrap-
ulmonary disease is higher in non UK-born cases [2]. TB
incidence has risen in Central Manchester between 2000
when there were 114 notifications and 2009 when there
were 196 [4].
Drug resistance makes management more complicated
and expensive and is an important cause of mortality and
morbidity. A gradual rise in some drug resistances is being
seen in the UK [2] in 2011 multi-drug resistance or MDR-TB
(resistance to at least rifampicin and isoniazid) was seen in
1.6% cases overall and resistance to at least one first line
antibiotic was seen in 8.4%. Internationally, the full extent
of drug resistance is unknown but China, Russia and India
appear to have the highest incidence. Countries in the
former Soviet Union have a high incidence of drug resis-
tance, coupled with low rates of sensitivity testing and
appropriate treatment [5].
It is therefore vital to obtain samples for microbiolog-
ical culture and sensitivity to provide absolute confirma-
tion of the diagnosis of tuberculosis and to ensure
adequate treatment and prevent spread of drug-resistant
disease.
In Central Manchester we have seen an increase in the
proportion of cases where samples were sent for microbi-
ological confirmation. 69% had samples sent to microbiology
in 2000 and 79% in 2009 [6], but despite this we have been
concerned there may have been missed opportunities to
obtain proof of the causative organism. We therefore un-
dertook this study to investigate how often we sent samples
and how often we achieved microbiological confirmation of
TB. We examined what factors affected both sampling and
culture results. In addition, we further investigated cases
where there were no samples or negative cultures to assesswhether there were missed opportunities for microbiolog-
ical confirmation.
Methods
A retrospective analysis was carried out on all cases (adult
and paediatric) diagnosed with TB at Central Manchester
NHS Foundation Trust (CMFT) in 2009 identified from our TB
database. CMFT is a 1400 bed hospital serving an inner-city
population with considerable ethnic diversity, typical of UK
cities. The TB unit co-ordinates the treatment of all active
TB in this population, regardless of disease site or under-
lying disease, with treatment adhering to NICE guidance.
Around 200 cases per year are seen (accounting for 1/4
cases in Northwest England), of which 50% are pulmonary
and 10% have co-existing HIV infection. TB cases in Man-
chester are similar to those in the rest of the UK, in terms of
ethnicity of patient and site of disease [2]. Central Man-
chester is however under resourced compared to other
cities regarding TB nurse to notification ratio and there has
recently been a significant increase in clinic numbers
compared to other UK cities [4].
TB cases were defined as any subjects who were notified
to the HPA as being treated for active TB or any subject
restarting TB treatment who had relapsed within 12 months
of previous treatment. No cases were retreated in the study
period and therefore no cases were counted twice. De-
mographic details, site of disease, types of specimens and
results of TB culture were recorded from computer records,
case notes and TB nurse records. Cases were analysed in
detail for reasons why specimens were not taken or culture
positivity was not confirmed. A judgement was made on
whether this was acceptable or non-acceptable manage-
ment based on the clinical circumstances surrounding the
case. Outcome data and relapse rates were also recorded.
Routine investigation of pulmonary TB at CMFT includes
obtaining 3 adequate sputum samples or bronchoscopic
samples, unless the procedure is contra-indicated. For non-
pulmonary disease, Fine needle aspiration (FNA) or biopsy
of disease site is routinely performed, except in ocular TB.
Clinically acceptable cases were deemed as those in which
in the view of the authors and doctors managing the patient
an acceptable balance was achieved between the need for
invasive procedures, potential harm to the patient and
delays in starting treatment, weighed against need to
commence treatment in a relatively short time frame.
Culture positivity and whether samples were sent for
culture were compared with site of disease, age of patient,
ethnic origin and sample type. Statistical analysis was
carried out using the software package SPSS. The Chi
squared test was used to compare numbers of samples sent
for culture and culture positivity with site of disease, age of
patient, ethnic origin and sample type.
Figure 1 Pulmonary TB in Central Manchester.
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There were 167 cases treated at CMFT in 2009. 11 cases
were withdrawn due to diagnosis occurring in other Trusts
leaving 156 cases. 69 cases (44%) were pulmonary (repre-
sented in Fig. 1), and 87 cases (56%) were extrapulmonary,
with the most common extrapulmonary sites being lymph
node, eye and pleura.
Samples not taken
The most common ethnic group in the cohort was Black/
African (31.4%), followed by Pakistani (23.7%), Caucasian
(16%) and Indian (10.9%). In total, 67.3% cases were born
outside the UK. 120 cases were in the age group 17e64
(77%). 20 cases (13%) were in children.
128 (82%) patients had one or more specimens sent to
microbiology for AAFB smear and culture. 28 (18%) patients
had no specimens sent to microbiology. Factors which wereTable 1 Frequency of samples sent for culture by disease
site.
Disease site n/Total % sent for culture
Pulmonary 62/69 89.8%
Pleura 10/10 100%
Lymph Nodes 28/34 82.4%
Abdominal 7/8 87.5%
Disseminated 6/6 100%
Eye 0/12 0%
Other 15/17 88.2%
Total 128/156 82%associated with whether samples were sent to microbiology
included disease site (p < 0.0001) (Table 1), with ocular dis-
ease being the least likely to be sampled, and patient age
(pZ 0.002) (Table 2). Children were less likely to have sam-
ples sent for culture, with 45% patients <16 years old having
no samples sent compared with 12.5% patients aged 16e64.
Ethnicity did not influence the frequency of sampling (n.s.).
Lack of specimens for culture was considered to be
clinically acceptable in 25/28 cases (Table 3). Reasons for
no sample included ocular disease (12 cases) and paediatric
cases (9 cases) where potentially unacceptable invasive
sampling would be required. The 3 potential missed cases
(2% overall cases, 11% samples not sent) were all in non UK-
born adults with abdominal disease who underwent invasive
procedures, but where biopsies taken were sent for his-
tology only.
Samples culture negative
Of the subjects who had samples sent, 72% were culture
positive and 28% were negative. There was a trend for
culture positivity to be more common in pulmonary disease
(75%) compared to non-pulmonary disease (46%) (n.s.).
Non-pulmonary culture positive rates also tended to be less
even in those where samples for culture had been taken:
40/66 (61%) non-pulmonary compared with 52/62 (84%) of
all samples taken for cases with pulmonary disease
(p Z 0.003). Culture negative results were associated with
patient age (p Z 0.019) and specimen type (p < 0.0001).
Again, children were less likely to have positive culture
results, with 64% cases <16 years old had negative culture
results compared with 26% 16e64 year olds (p Z 0.019)
(Table 2). Site of disease and ethnic origin did not signifi-
cantly affect culture results. However, only 12% sputum
samples were culture negative, compared to 43% lymph
node aspirates and 100% of cases in which multiple sites
were sampled (see Supplementary Table 1).
36/128 samples sent to microbiology were culture
negative (28% samples sent, 41% overall). Lack of a positive
culture was considered to be clinically acceptable in 32/36
cases which were culture negative (Table 4). The 4 cases
(3% overall cases, 11% culture negative cases) which could
have potentially been missed were due to pleural TB in
adult patients born outside the UK, all of which did not
have pleural biopsies. Many of the acceptable cases were in
children or in cases where reasonable attempts to make a
microbiological diagnosis had been made. 10 cases of pul-
monary TB were culture negative, of which 2 were children.
2/3 children had gastric lavages and of the adults five
had  three sputum samples examined, one had a bron-
choscopic sample examined and one had 2 sputum samples,
one BAL, CSF and urine sample examined.
None of the culture negative cases or cases with no
samples sent relapsed after treatment and all completed 6
months of treatment and were then discharged from the TB
service.
Discussion
The most important finding of this study is that despite the
overall low culture positive rate (59%), especially in those
Table 2 Frequency of samples sent for culture and culture positivity by age group.
Age group Number sent for culture/Total % sent for culture Number culture positive/Total % culture positive
p Z 0.002 p Z 0.019
<16 11/20 55% 4/11 36.3%
16-64 105/120 87.5% 78/105 74.2%
>64 12/16 75% 10/12 83.3%
Total 128/156 82.1% 92/128 71.8%
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obtain samples for culture were missed in relatively few
cases. Similar proportions of culture confirmation were also
seen nationally (overall 59%, pulmonary 70%, and extrap-
ulmonary 45%) [2]. Extrapulmonary TB may be difficult to
sample, as more invasive procedures are necessary. At
CMFT, TB treatment is commenced after samples for
microbiological confirmation have been obtained. TB
treatment is unlikely to have influenced our findings
therefore.
We have demonstrated an association between site of
disease and the frequency of sampling. This is to be ex-
pected as some sites are easier and less hazardous to
sample. 0/12 cases of presumed ocular TB had specimens
sent for microbiological confirmation. Our centre has a high
incidence of ocular TB as it is a tertiary referral centre for
the North-West. A recent study of patients presenting with
uveitis and evidence of active TB elsewhere or evidence of
latent TB revealed that in 70% cases, inflammation resolved
after a 6 month course of antituberculous therapy [7].
Thus, an approach of treatment based on characteristic
clinical findings, with no other cause identified may be
justified. Polymerase chain reaction (PCR) has been sug-
gested as a diagnostic tool for detection of mycobacterial
DNA in aqueous humor [8]. However, the sensitivity and
specificity of this method has yet to be proven and the
process is invasive.
Disease site was not related to whether TB cultures were
positive. However, some sites only had few samples so it is
difficult to draw conclusions. The type of sample taken was
related to whether culture positivity was confirmed. 14
cases had lymph node aspirates sent for culture (including
cases where samples may also have been taken from other
sites), but only 50% returned positive. Lymph nodeTable 3 A summary of cases with no specimen sent.
Site of disease Number No sample
Pulmonary 69 7
Lymph node 34 6
Gastrointestinal 8 1
Eye 12 12
Testicle 1 1
Cryptic 1 1aspirates have previously been demonstrated to yield be-
tween 46% and 62% positive results [9,10]. Lymph node bi-
opsy increases culture positivity (71e97% [9,10], and in our
study 89%), but is not available as quickly and more inva-
sive. Use of endobronchial ultrasound guided sampling
(EBUS) is a welcome advance, but culture positive rates
even with this technique remain of the order of 50% [11].
Other specimens which yielded poor culture positivity were
gastric aspirates (0%) and samples from multiple sites (0%).
Our laboratory does not add bicarbonate to gastric samples
prior to culture and so our culture data is lower than that
reported in the literature (17.2%) [12]. However, there
were only 4 gastric aspirates sent in our cohort, so it is
difficult to draw robust conclusions from this. Most of the
cases where samples were taken from multiple sites were
either lymph node disease (n Z 5) or disseminated disease
(n Z 4). All these were in non-UK born cases and history
and radiology was highly suggestive of TB.
Whether samples were sent for culture also depended on
patient age, with children less likely to be sampled. Sam-
pling in children is more difficult than in adults. Hilar
lymphadenopathy was the disease site in 7 of these cases
and therefore would require invasive procedures to sample,
which would involve risk, distress and general anaesthesia.
The advent of EBUS may also be of use in the future in
children [13].
Paediatric samples were also more likely to be culture
negative. In children, gastric lavage has been the investi-
gation of choice for pulmonary TB as it is relatively easy to
perform and less invasive than bronchoscopy. Disease in
children is typically paucibacillary so the yield of direct
acid fast smear microscopy in sputum is low, and prolonged
culture is needed [14]. However, the yield from gastric
lavage is often also low (32%) [15] so new techniques forReasons for no sample
5 children age <8
1 85 yr old on LCP
1 age 31 refused bronchoscopy
3 children with hilar nodes
1 node had gone by time of biopsy
1 pelvic node in patient with cervical cancer
1 abdo node sampled at renal transplant
84 yr old caecal biopsy only sent to histology
Inaccessible
Biopsy to histology only
No site to sample
Table 4 A summary of cases with negative microbiology.
Site of disease Number Culture -ve Reasons for negative sample
Pulmonary 69 10 2 children age <1 yr old
4 sputum only - 2 had 3 sputums taken
- 1 had 1 sputum taken before placed on treatment (high risk renal patient)
- 1 had 1 sputum taken before placed on treatment (high risk HIV patient)
1 had bronchoscopy, CSF and urine examined
1 bronchoscopy only
2 sputum and bronchoscopy
Lymph node 34 12 3 children with hilar nodes
1 node biopsy only
6 node aspirates þ other site but with no node biopsy. 29e62 yr old.
1 node aspirate failed due to solidification of pus. Biopsy delayed
until after treatment
1 node aspirate failed because node could not be palpated.
(sputum x3, renal biopsy and urine taken)
Gastrointestinal 8 2 1 27 yr old had 6 sputum samples taken.
1 ascites aspirate taken only.
Pleura 10 3 3 pleural aspirates only, no biopsy.
Disseminated 6 3 1 pleura and abdo disease. Ascites and pleural aspirate taken.
A&E admission so no time for biopsy.
1 pleura and LN disease. 12 yrs old therefore pleural aspirate and
nasogastric secretions only.
1 pleura and LN disease. Pleural aspirate and bronchoscopy only. No biopsy
Bone/joint 4 1 Joint aspirate
Miliary 2 1 Sputum and gastric lavage (child)
CNS 3 1 Spinal aspirate
Skin 2 1 Skin biopsy
Nasal 2 1 Nasal swab
Pericardium 1 1 Pericardial and pleural aspirates
2026 Z. Al-Nakeeb et al.diagnosing TB in children are emerging: principally induced
sputum [14] and nasopharyngeal aspiration [16].
Ethnicity of individuals was not related to whether
samples were sent for culture or were culture positive. This
is again to be expected but important given that cases in
ethnic minorities are more likely to be extrapulmonary and
have higher levels of drug resistance. Isoniazid resistance
and MDR-TB are more common in ethnic minorities and
individuals born outside the UK [17]. HPA figures have
demonstrated 7.4% cases non UK-born have isoniazid
resistance, compared to 6.3% UK born. In addition, 1.4%
cases born outside the UK have MDR TB, in comparison with
0.6% UK born cases. In Central Manchester in 2009 4.7% of
cases showed monoresistance and 0% MDR-TB.
In only 3/28 cases with absent samples was this consid-
ered to be non-acceptable. 2 cases involved lymph nodes in
the abdomen and pelvis and 1 involved ileocaecal disease,
in which samples were taken for histology only during sur-
gical or endoscopic procedures. The patients were all born
outside the UK in areas with high TB incidence. TB may not
have been considered in the initial differential diagnosis
highlighting the need for ongoing education and awareness
for healthcare professionals. In addition, these procedures
were likely to have been performed by surgeons who come
across TB infrequently and therefore would only have
formalin in which to place samples. Other specialties e.g.
radiology may be more used to sending samples formycobacterial culture. A previous retrospective analysis of
abdominal TB at a centre in the UK revealed culture posi-
tive results in 39% cases overall [18]. When biopsies are
taken, the culture positive rate can vary between 6% and
69% [19], again indicating the difficulties of confirming drug
sensitivity in this disease. At CMFT TB culture was
confirmed in 63% cases of abdominal TB.
When samples were sent for culture, 72% gave a culture
positive result, giving an overall proportion of 59% cases
being culture positive in our case series. Only 4 of these
cases could have been managed differently on retrospec-
tive analysis. If samples are smear negative, culture re-
sults and sensitivity confirmation can take up to 6 weeks.
The clinician often needs to start treatment before this
and by the time negative results are returned, it may be
too late for repeat sampling. Most centres will have had
experience with histopathology results revealing caseating
granulomas in high risk individuals but no positive micro-
biological cultures. The overall sensitivity of TB culture
has been reported to be 80e85%, and the specificity
98% [20].
The 4 cases which could have been managed differently
all involved adults born outside the UK with pleural effu-
sions, where pleural fluid was sent for culture but no
pleural biopsy was done. Pleural fluid is known to have low
culture sensitivity (<40%) but pleural biopsy increases
diagnostic yield to 91%, with culture confirmation in 56%
Diagnosis of TB by microbial culture 2027[21]. A recent case series also demonstrated that 55% in-
dividuals with tuberculous effusions will have positive cul-
tures from induced sputum, another diagnostic tool which
could be utilised [22].
Limitations of our study include diagnosis of TB in a
single centre and therefore potential for lack of general-
isability. Central Manchester NHS Foundation Trust also has
a regional ophthalmology unit, accounting for the rela-
tively high proportion of ocular TB. Our findings could be
used to base a multi-centre study to allow a bigger sample
size which may be more representative. There may be
some subjectivity when defining what is acceptable to
have been missed or not. The researchers have made a
decision based on documentation in medical and nursing
notes, on a retrospective basis. The results of all in-
vestigations and discussions may not have been available
for review, and therefore may have lead to bias in
interpretation.
Despite an overall culture positive rate of 59%, none of
the patients in whom no samples were sent or were cul-
ture negative relapsed and all were discharged from the
TB service. A previous study has also demonstrated that
empirical treatment of pulmonary TB based on clinical
and radiological features did not lead to any adverse
outcomes in culture negative patients in whom the
development of resistance might be expected to be less
likely to occur [23,24]. The setting of the study is typical
of practice throughout the UK and probably many other
centres. The lack of an obvious and easy capability to
increase culture positivity must be a concern, especially
in this era of increasing extrapulmonary TB. Novel ap-
proaches (eg EBUS examination of mediastinal nodes) to
invasive sampling and improvements in microbiological
methods are going to be important for future successful
case management.
Conclusions
In summary, culture positivity is slowly increasing, and is
more common in pulmonary than extrapulmonary disease.
The rise in the proportion of extrapulmonary cases and
the lower culture positivity rate in this group is a partic-
ular concern. There were very few cases overall where
opportunities to obtain samples and/or confirm culture
and sensitivity were reasonably missed. In this era of drug
resistance there is an increased need for invasive methods
to provide samples for culture and improved microbio-
logical methods to ensure correctly targeted anti-
tuberculous therapy in the individual patient and to
accurately describe the pattern of drug resistance in the
population.
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